Table 11

Dhanlakshmi Effects on Prenatal and Pregnancy Outcomes, DLHS 2007/08 and 2012/2013

DL × PostP-ValueNR2
(1)(2)(3)(4)
No. of days ifa tablets taken8.416(0.039)4,5620.0989
Received tetanus injection0.137(0.000)6,7010.0430
Swelling of hands, feet and face−0.0526(0.003)6,6510.011
Paleness/giddiness/weakness−0.0757(0.003)6,6510.0525
Visual disturbances−0.0327(0.016)6,6510.0183
Excessive fatigue−0.131(0.000)6,6510.040
Convulsions not from fever0.0696(0.000)6,6510.0203
Weak or no movement of fetus−0.0405(0.000)6,6510.0122
Abnormal fetal position−0.0503(0.000)6,6510.0115
Malaria0.00239(0.565)6,6510.0104
Excessive vomiting−0.0146(0.375)6,6510.0235
Hypertension/high bp−0.0805(0.000)6,6510.0108
Jaundice−0.0229(0.000)6,6510.00612
Excessive bleeding−0.00242(0.582)6,6510.00823
Vaginal discharge−0.0167(0.001)6,6510.0121
  • Notes: DLHS sample of mothers (6,701) who responded to the prenatal care questionnaire. The outcome variable is a binary indicator for whether a mother received antenatal care or reported having a problem at her most recent pregnancy. DID estimates compare the change in each outcome during 2004–2007 and 2009–2012 in Fatehgarh Sahib with the corresponding changes in the control districts. Added controls include mother’s age and education, household’s caste, religion, location (rural or urban), and an indicator of dwelling construction type (wealth proxy). p-values based on CR standard errors in parentheses.